Literature DB >> 1967665

Antistreptokinase titres after intravenous streptokinase.

S Jalihal1, G K Morris.   

Abstract

Streptokinase neutralisation titres were measured in a series of 25 patients who received streptokinase for the treatment of acute myocardial infarction. Before treatment, neutralisation titres were low (0.3 X 10(6) neutralisation units or less) in all patients. 3 months after treatment, neutralisation titres in 24 were such that a typical therapeutic dose of 1.5 million units of streptokinase would have been fully neutralised. At 4 1/2-8 1/2 months, 18 of 20 patients had neutralisation titres such that at least 50% of a dose of 1.5 million units of streptokinase would have been neutralised. After 8 months, neutralisation titres ranged from 0.4 to 2.0 million units in 8 patients. A decision to readminister streptokinase within 8 months (and probably up to 1 year) of previous thrombolytic treatment should take account of the neutralising capacity of plasma and the dose should be adjusted accordingly.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1967665     DOI: 10.1016/0140-6736(90)90276-b

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  22 in total

1.  BTS guidelines for the management of pleural infection.

Authors:  C W H Davies; F V Gleeson; R J O Davies
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

2.  Immunoglobulin response to intravenous streptokinase in acute myocardial infarction.

Authors:  S C Grant
Journal:  Br Heart J       Date:  1992-05

3.  Serum sickness and purpura following intravenous streptokinase.

Authors:  G J Clesham; H J Terry; S Jalihal; P J Toghill
Journal:  J R Soc Med       Date:  1992-10       Impact factor: 5.344

4.  ISIS 3: the last word on thrombolysis?

Authors:  S Cobbe
Journal:  BMJ       Date:  1992-06-06

5.  Thrombolytic treatment for recurrent myocardial infarction.

Authors:  H White
Journal:  BMJ       Date:  1991-02-23

Review 6.  Dangers of thrombolysis.

Authors:  M C Petch
Journal:  BMJ       Date:  1990-02-24

7.  Coronary thrombolysis: round two and beyond.

Authors:  R G Wilcox
Journal:  Br Heart J       Date:  1991-04

Review 8.  Is the development of antibodies to streptokinase clinically relevant?

Authors:  M B Buchalter
Journal:  Drugs       Date:  1994-08       Impact factor: 9.546

9.  Streptokinase neutralisation titres up to 866 days after intravenous streptokinase for acute myocardial infarction.

Authors:  S Patel; S Jalihal; D P Dutka; G K Morris
Journal:  Br Heart J       Date:  1993-08

10.  Monitoring of streptokinase resistance titre in acute myocardial infarction patients up to 30 months after giving streptokinase or anistreplase and related studies to measure specific antistreptokinase IgG.

Authors:  R Fears; H Ferres; E Glasgow; R Standring; K J Hogg; J D Gemmill; J M Burns; A P Rae; F G Dunn; W S Hillis
Journal:  Br Heart J       Date:  1992-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.